A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)
Clinical trial NCT05279456 · COMPLETED
Trial details
- NCT number
- NCT05279456
- Sponsor
- Vaxine Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-15
- Primary completion
- 2023-12-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.